Back to Search
Start Over
Anti-HER2 Antibody, Trastuzumab in Patients with Recurrent or Refractory Ovarian or Primary Peritoneal Carcinoma with Overexpression of HER2
- Source :
- Clinical Oncology Alert. March 1, 2003
- Publication Year :
- 2003
-
Abstract
- Anti-HER2 Antibody, Trastuzumab in Patients with Recurrent or Refractory Ovarian or Primary Peritoneal Carcinoma with Overexpression of HER2 Abstract & Commentary Synopsis: The clinical value of single-agent trastuzumab in recurrent [...]
Details
- Language :
- English
- ISSN :
- 08867186
- Database :
- Gale General OneFile
- Journal :
- Clinical Oncology Alert
- Publication Type :
- News
- Accession number :
- edsgcl.206595047